Silicon Valley Capital Partners’s AstraZeneca AZN Stock Holding History

Silicon Valley Capital Partners’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-280	Closed	-$41.3K	–	308
2025 Q1	$41.3K	Buy	280 +4	+1%	+$579	0.01%	143
2024 Q4	$36.2K	Hold	276	–	–	﹤0.01%	160
2024 Q3	$43K	Buy	276 +1	+0.4%	+$161	0.01%	141
2024 Q2	$42.8K	Hold	275	–	–	0.01%	136
2024 Q1	$37.2K	Buy	275 +4	+1%	+$530	0.01%	135
2023 Q4	$36.4K	Sell	271 -30	-10%	-$3.9K	0.01%	120
2023 Q3	$40.7K	Buy	301 +2	+0.7%	+$273	0.01%	104
2023 Q2	$42.7K	Buy	299 +269	+897%	+$39.6K	0.01%	104
2023 Q1	$4.13K	Hold	30	–	–	﹤0.01%	200
2022 Q4	$3.98K	Buy	+30	New	+$3.76K	﹤0.01%	165

Other funds holding AZN

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fisher Asset Management

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Sanders Capital

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return